Dawn Quelle receives Oberley Seed Grant Award
Dawn Quelle received an Oberley seed grant award from the Holden Comprehensive Cancer Center to examine “Serotonin regulation by RABL6A in neuroendocrine tumors.” Elevated serotonin is the major factor driving carcinoid syndrome (CS) in patients with metastatic small bowel neuroendocrine tumors...